Exeliom Biosciences

Updated: March 19, 2026
Benjamin Hadida, Co-founder, CEO
Benjamin Hadida, Co-founder, CEO
Country: France | Funding: €22.3M (+)
Founded: 2016

Website: https://www.exeliombio.com/

Exeliom Biosciences develops a bacterial treatment for inflammatory bowel diseases. It's intended to rebalance the gut microbiome through the delivery of Faecalibacterium prausnitzii, one of the most abundant species of bacteria in the gut.

Competitors